Kilitch Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kilitch Drugs has informed the stock exchanges that the trading window for dealing in its shares will be closed for all designated persons and their immediate relatives starting Wednesday, April 1, 2026. The closure will remain in effect until 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2026. The date of the board meeting to approve these results will be communicated separately. This is a standard regulatory compliance measure under SEBI's insider trading norms.
This is a routine compliance filing and does not have a direct impact on shareholders or the stock price. The upcoming audited Q4 and full-year FY26 results will be the key catalyst, and investors should watch for the board meeting date announcement for any business updates.